MGC Diagnostics Corporation, is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its subsidiary MedicalGraphics Corporation, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company’s products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians’ offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.

We are committed to improving the quality of life of people around the world with innovative productsthat apply our core technologies to realize a society in which people enjoy lives of good health and abundance.In the past, the respiratory business focused on the oxygen concentrator business for rental operators and patients. However, CAIRE Inc’s acquisition of MGC Diagnostics late last year enabled the company togain a product portfolio of cardiopulmonary diagnostic equipment and a sales channel for medical institutions.Going forward, we will aim to provide comprehensive solutions for respiratory patients, such as thosewith COPD and asthma. We will additionally aim for further growth of our business through the development of products that meet the needs of each region as well as the expansions of our product portfolios.

CAIRE Inc., the leading global manufacturer of oxygen therapy and on-site generation systems, has finalized the acquisition of St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). This acquisition strengthens CAIRE’s position and focus on diagnostic technologies — furthering expanding its expertise in serving patients throughout the progression of pulmonary disease.Through this expansion of its time-proven portfolio of personal portable and stationary oxygen therapy solutions, and larger onsite generation solutions, CAIRE adds MGC’s well-respected brand of non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease.Acquired by NGK SPARK PLUG in 2018, CAIRE is poised for continued growth as the organization further expands its portfolio of solutions to serve the greater medical and healthcare markets, a part of its overall diversification outside of its core internal combustion engine business.

MGC Diagnostics Corporation, is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its subsidiary MedicalGraphics Corporation, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company’s products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians’ offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.

MGC Diagnostics is a global medical technology company dedicated to Cardio-Respiratory health solutions. Our singular focus guides our strategy and our scale defines our commitment to customers, employees and shareholders. These attributes make us uniquely qualified to solve today’s challenges and uncover solutions for tomorrow’s opportunities.

ERT is the one experienced partner to turn to for best-in-class solutions and best-in-class advisement, whenever you need to collect and manage clinical data to deliver quality results that support getting your new drugs to market.

LabRetriever’s™ Practice Management EMR is specifically designed for sleep labs of any size, from free-standing to enterprise class systems. Providing access to the latest technology, affording reductions in IT spend and reduced regulatory risk.LabRetriever™ delivers referral capture, directed workflow, unified scheduling, outcome reporting, therapy prescription and patient communication.LabRetriever™ is your end-to-end solution